IL-32γ reduces lung cancer cell growth in vitro and in vivo by inhibiting the binding of NFκB-dependent DNA (cytosine-5)-methyltransferase 1 (DNMT1) to TIMP3 promoter and thus increased TIMP3 expression contributes to the inhibition of cancer growth [52]. Here, TIMP3 is linked to lung carcinoma.